Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake - PubMed (original) (raw)
Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake
Raewyn C Poulsen et al. Am J Hematol. 2008 Jun.
Free article
Abstract
Newly described lipoxygenase (LOX)-generated lipid mediators, that is, resolvins and protectins as well as lipoxins, are both anti-inflammatory and proresolving. We aimed to determine whether these lipid mediators are present in bone marrow and whether their lipidomic profiles are altered following ovariectomy or dietary supplementation with eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA) ethyl esters. Female rats were ovariectomised or sham-operated. Shams and one ovariectomised group received a diet devoid of omega-3 long-chain polyunsaturated fatty acids. The remaining ovariectomised rats received either 0.5 g EPA or DHA ethyl ester/kg body weight/day for 4 months. Bone marrow was analyzed using both GC to determine fatty acid composition and mediator lipidomics by LC/MS/MS profiling for the presence of LOX-pathway lipid mediators derived from arachidonic acid (AA), EPA, and DHA. LOX-derived products including lipoxins, resolvin D1, resolvin E1, and protectin D1 were identified in bone marrow by the presence of diagnostic ions in their corresponding MS-MS spectra. The proportion of AA relative to DHA and of AA-derived relative to DHA-derived mediators in bone marrow was higher in ovariectomised compared to sham-operated rats. DHA or EPA ethyl ester supplementation increased the percentage of DHA and EPA in bone marrow and increased the proportion of LOX mediators biosynthesized from DHA or EPA, respectively. Given the potent bioactivities of the lipoxins, resolvins, and protectins, the presence and changes in profile postovariectomy and with EPA and DHA ethyl ester supplementation may be of interest in bone marrow function and as a potential source of these mediators in vivo.
Copyright 2008 Wiley-Liss, Inc.
Comment in
- Inflammation resolution: does the bone marrow have a say?
Romano M. Romano M. Am J Hematol. 2008 Jun;83(6):435-6. doi: 10.1002/ajh.21202. Am J Hematol. 2008. PMID: 18429053 Review. No abstract available.
Similar articles
- Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation.
Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B. Weylandt KH, et al. Prostaglandins Other Lipid Mediat. 2012 Mar;97(3-4):73-82. doi: 10.1016/j.prostaglandins.2012.01.005. Epub 2012 Feb 3. Prostaglandins Other Lipid Mediat. 2012. PMID: 22326554 Review. - Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
Markworth JF, Kaur G, Miller EG, Larsen AE, Sinclair AJ, Maddipati KR, Cameron-Smith D. Markworth JF, et al. FASEB J. 2016 Nov;30(11):3714-3725. doi: 10.1096/fj.201600360R. Epub 2016 Jul 26. FASEB J. 2016. PMID: 27461565 Free PMC article. - Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammation.
Dasilva G, Pazos M, García-Egido E, Gallardo JM, Rodríguez I, Cela R, Medina I. Dasilva G, et al. J Nutr Biochem. 2015 Nov;26(11):1385-92. doi: 10.1016/j.jnutbio.2015.07.007. Epub 2015 Jul 26. J Nutr Biochem. 2015. PMID: 26320676 - Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
Pauwels EK, Kostkiewicz M. Pauwels EK, et al. Drug News Perspect. 2008 Dec;21(10):552-61. doi: 10.1358/dnp.2008.21.10.1314058. Drug News Perspect. 2008. PMID: 19221636 Review. - Risk stratification by the "EPA+DHA level" and the "EPA/AA ratio" focus on anti-inflammatory and antiarrhythmogenic effects of long-chain omega-3 fatty acids.
Rupp H, Wagner D, Rupp T, Schulte LM, Maisch B. Rupp H, et al. Herz. 2004 Nov;29(7):673-85. doi: 10.1007/s00059-004-2602-4. Herz. 2004. PMID: 15580322 Review.
Cited by
- Association Between Dietary Intake After Roux-en-Y Gastric Bypass Surgery and Antioxidant/inflammatory Status: A 6-Month Pilot Prospective Cohort Study.
Hatami M, Haghighat N, Sohrabi Z, Javanbakht MH, Pazouki A, Farsani GM. Hatami M, et al. Obes Surg. 2024 Jul;34(7):2499-2507. doi: 10.1007/s11695-024-07293-3. Epub 2024 Jun 7. Obes Surg. 2024. PMID: 38848028 - Fatty Acid Intake and Polyunsaturated Fatty Acid Biomarkers and Risk of Total Knee or Hip Arthroplasty Among Older Women in the Women's Health Initiative.
Orchard T, McLaughlin E, Winschel T, Shadyab A, Laddu D, Vitolins M, Constantinescu F, Jackson R. Orchard T, et al. Arthritis Care Res (Hoboken). 2024 Jul;76(7):993-1005. doi: 10.1002/acr.25319. Epub 2024 Apr 1. Arthritis Care Res (Hoboken). 2024. PMID: 38412867 - Intra-articular bone marrow mononuclear cell therapy improves lameness from naturally occurring equine osteoarthritis.
Everett JB, Menarim BC, Barrett SH, Bogers SH, Byron CR, Pleasant RS, Werre SR, Dahlgren LA. Everett JB, et al. Front Vet Sci. 2023 Oct 9;10:1256284. doi: 10.3389/fvets.2023.1256284. eCollection 2023. Front Vet Sci. 2023. PMID: 37876630 Free PMC article. - Characterization of serum polyunsaturated fatty acid profile in patients with inflammatory bowel disease.
Jiang J, Chen L, Sun R, Yu T, Jiang S, Chen H. Jiang J, et al. Ther Adv Chronic Dis. 2023 Feb 28;14:20406223231156826. doi: 10.1177/20406223231156826. eCollection 2023. Ther Adv Chronic Dis. 2023. PMID: 37008284 Free PMC article. - Anti-Inflammatory and Antioxidant Properties of Malapterurus electricus Skin Fish Methanolic Extract in Arthritic Rats: Therapeutic and Protective Effects.
Elmaidomy AH, Mohamed EM, Aly HF, Younis EA, Shams SGE, Altemani FH, Alzubaidi MA, Almaghrabi M, Harbi AA, Alsenani F, Sayed AM, Abdelmohsen UR. Elmaidomy AH, et al. Mar Drugs. 2022 Oct 14;20(10):639. doi: 10.3390/md20100639. Mar Drugs. 2022. PMID: 36286462 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous